Patents (1354 Stem Cell Patents)

Class: Extraction/Preservation (151)

Order by:
<< | < | 8 9 10 11 12 13 14 15 16 | > | >>


Method to produce novel embryonic cell populations

Patent Number: 6110739

This patent covers generation of cells from embryonic stem cells, and subsequent immortalization of the generated cells. The generated cells may be semidifferentiated stem cells or precursor cells. Immortalization may be accomplished by transfection with the gene HOX 11.

Inventors: Keller, Gordon M. (Denver, CO); Hawley, Robert G. (Toronto, CA); Choi, Kyunghee (Baltimore, MD)
Assignee: National Jewish Medical and Research Center (Denver, CO)
Date of First Priority Issue: Monday November 21st, 1994

Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof

Patent Number: 5677136

This patent teaches that the protein CD59 may be used as a marker of hematopoietic stem cells both for identification, and also for purification.

Inventors: Simmons, Paul J. (Adelaide, AU); Hill, Beth L. (Mountain View, CA); Chen, Benjamin P. (Fremont, CA)
Assignee: Systemix, Inc. (Palo Alto, CA)
Date of First Priority Issue: Monday November 14th, 1994

Method of purifying a population of cells enriched for hematopoietic stem cells populations of cells obtained thereby and methods of use thereof

Patent Number: 5665557

This patent covers the use of CDw109 for purification and identification of hematopoietic stem cells.

Inventors: Murray, Lesley (San Jose, CA); Sutherland, D. Robert (Oakville, CA)
Assignee: Systemix, Inc. (Palo Alto, CA) The Toronto Hospital Research Institute (Toronto, CA)
Date of First Priority Issue: Monday November 14th, 1994

Neural cell protein marker RR/B and DNA encoding the same

Patent Number: 6066451

This patent provides a marker for the identification of specific neural cells. This marker is useful for knowing the quantity and quality of neurons generated from various stem cell populations.

Inventors: Avraham, Shalom (Brookline, MA); Avraham, Hava (Brookline, MA); Groopman, Jerome E. (Brookline, MA)
Assignee: Beth Israel Deaconess Medical Center, Inc. (Boston, MA)
Date of First Priority Issue: Monday October 3rd, 1994

Method of selecting pluripotent hematopioetic progenitor cells

Patent Number: 5827742

This patent takes advantage of the fact that early hematopoietic stem cells are usually CD34+ and quiescent. By treatment of CD34+ cells with cytotoxic agents that kill proliferating cells, a population of primitive stem cells may be obtained.

Inventor: Scadden, David T. (Weston, MA)
Assignee: Beth Israel Deaconess Medical Center, Inc. (Boston, MA)
Date of First Priority Issue: Thursday September 1st, 1994

Isolation, selection and propagation of animal transgenic stem cells

Patent Number: 6878542

This patent appears to be a really unique way of expanding stem cells. Essentially the patent teaches to connect a growth factor receptor to a promoter that is only expressed on stem cells, such as the promoter for Oct-4. This way stem cells will express the growth factor receptor. This way if you add the ligand for the receptor the stem cells will proliferate...

Inventors: Smith, Austin Gerard (Edinburgh, GB); Mountford, Peter Scott (Elsdenwid, AU)
Assignee: The University of Edinburgh (GB)
Date of First Priority Issue: Thursday April 21st, 1994

Method of enriching for mammalian stem cells

Patent Number: 6146888

In this patent an antibiotic resistance gene is placed under the control of a promoter associated with stem cells. This way only the stem cells will live while the other cells will die when exposed to the antibiotic.

Inventors: Smith, Austin Gerard (Edinburgh, GB); Mountford, Peter Scott (Elsfernwid, AU)
Assignee: The University of Edinburgh (GB)
Date of First Priority Issue: Thursday April 21st, 1994

Myocardial grafts and cellular compositions useful for same

Patent Number: 6399300

This patent teaches ways of purifying out cells expressing myocardial genes from a heterogeneous population of stem cells. Specifically the patent teaches the use of cardiac specific promoters driving expression of markers that can be used to take the cells desired out of a heterogeneous population of cells.

Inventor: Field, Loren J. (Indianapolis, IN)
Assignee: Indiana University Foundation (Bloomington, IN)
Date of First Priority Issue: Tuesday November 16th, 1993

In vitro method for producing differentiated universally compatible human blood cells

Patent Number: 5811301

This patent teaches ways of genetically modifying stem cells, and their progeny so as to generate a population of cells that is acceptable by all humanity.

Inventor: Cameron, Robert B. (San Francisco, CA)
Assignee: None Stated
Date of First Priority Issue: Tuesday November 16th, 1993

Method to distinguish hematopoietic progenitor cells

Patent Number: 6555324

This patent covers methods for identifying hematopoietic stem cells based on expression of markers such as CD34, CD38, and various growth factor receptors.

Inventors: Olweus, Johanna (Fremont, CA); Lund-Johansen, Fridtjof (Fremont, CA); Terstappen, Leon Wmm (Palo Alto, CA)
Assignee: Becton Dickinson & Company (Franklin Lakes, NJ)
Date of First Priority Issue: Thursday November 4th, 1993

Order by:
<< | < | 8 9 10 11 12 13 14 15 16 | > | >>




Home | News | Patents | Products | Journal | Jobs | Search | RSS

About | Advisory Board | Newsletter | Advertise | Contact | Sitemap | Privacy Policy | Terms of Use

Copyright © 2006 - 2008 StemCellPatents.com - All rights reserved. - Toronto Web Design

StemCellPatents.com V2.03